Italy Viscosupplementation Market Size & Outlook
Italy viscosupplementation market, 2018-2030 (US$M)
Related Markets
Italy viscosupplementation market highlights
- The Italy viscosupplementation market generated a revenue of USD 74.8 million in 2023 and is expected to reach USD 149.7 million by 2030.
- The Italy market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 74.8 million |
| Market revenue in 2030 | USD 149.7 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Italy accounted for 1.6% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, France viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 270.0 million by 2030.
Single injection was the largest segment with a revenue share of 42.78% in 2023. Horizon Databook has segmented the Italy viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
According to Italian Health Ministry, osteoarthritis resulted to be the seventh out of 283 diagnosis for Clinical Classifications Software (CCS) for number of hospital discharges from hospital data collected in 2014. Hospital discharges for osteoarthritis in Italy were 127,000, close to the 2% of the discharges with an average hospital stay of 7.5 days.
As far as it concerns around 65,000 knee joint substitution surgeries were performed with an annual increasing rate of 7.2%. The prevalence of osteoarthritis increased with the rising incidence of total joint arthroplasty. OA disease has a significant impact on patient quality of life causing pain, stiffness and decreased joint functionality, leading to reduction of social life and partial loss of work productivity.
For instance, according to study, from 2001 to 2016, around 800 thousand primary Total knee arthroplasty (TKA) were operated in Italy on patients over 40. The total number of surgeries grew by 262% with an average annual growth rate of 6.6%.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy viscosupplementation market size, by product, 2018-2030 (US$M)
Italy Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
